Amber Biolife Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
Amber Biolife General Information
Description
Developer of biologic therapeutic products. The company p is focused on the development and commercialization of a novel processed human platelet lysate technology (Aurarix) as a stem cell growth supplement (UltraGro Advanced) and as a biologic eye drop for dry eye syndrome (Elate Ocular).
Contact Information
Website
www.amberbiolife.comCorporate Office
- Seattle, WA
- United States
Corporate Office
- Seattle, WA
- United States
Amber Biolife Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Amber Biolife FAQs
-
When was Amber Biolife founded?
Amber Biolife was founded in 2014.
-
Where is Amber Biolife headquartered?
Amber Biolife is headquartered in Seattle, WA.
-
What industry is Amber Biolife in?
Amber Biolife’s primary industry is Biotechnology.
-
Is Amber Biolife a private or public company?
Amber Biolife is a Private company.
-
What is Amber Biolife’s current revenue?
The current revenue for Amber Biolife is
. -
How much funding has Amber Biolife raised over time?
Amber Biolife has raised $690K.
-
When was Amber Biolife acquired?
Amber Biolife was acquired on 14-Aug-2015.
-
Who acquired Amber Biolife?
Amber Biolife was acquired by Zheng Yang Biomedical Technology Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »